Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 4/2015

01.12.2015 | Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Long-Term Sequela of Pediatric Bladder Reconstruction

verfasst von: Joshua Roth, Alison Keenan, Mark Cain, Benjamin Whittam

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Children with refractory neurogenic bladder (NGB) who have failed maximal medical management are presented with options for bladder reconstruction. It is critical to understand the long-term sequela of bladder augmentation and bladder neck reconstruction to properly counsel families regarding these procedures. Benefits may include preservation of renal function, continence, reduced risk of renal-related mortality, and potential improvements in quality of life (QOL). However, these advantages must be balanced with the risks of bladder calculi, perforation, need for additional surgery, acid/base disturbances, vitamin B12 deficiency, and malignancy. Therefore, careful patient selection and preoperative counseling are paramount for those undergoing bladder reconstruction which includes intestinal bladder augmentation, as these patients require lifelong vigilant follow-up.
Literatur
1.
McGuire EJ, Woodside JR, Borden TA, et al. Prognostic value of urodynamic testing in myelodysplastic patients. 1981. J Urol. 2002;167(2 Pt 2):1049–53. discussion 1054.CrossRefPubMed
2.
3.••
Szymanski KM, Misseri R, Whittam B, et al. Mortality after bladder augmentation in children with spina bifida. J Urol. 2015;195(2):643–8. Paper reported no death from bladder perforation or renal failure following enterocystoplasty.CrossRef
4.
Malakounides G, Lee F, Murphy F, et al. Single centre experience: long term outcomes in spina bifida patients. J Pediatr Urol. 2013;9(5):585–9.CrossRefPubMed
5.
Hubert KC, Large T, Leiser J, et al. Long-term renal functional outcomes after primary gastrocystoplasty. J Urol. 2015;193:2079–85.CrossRefPubMed
6.
Cher ML, Allen TD. Continence in the myelodysplastic patient following enterocystoplasty. J Urol. 1993;149(5):1103–6.PubMed
7.
Raezer DM, Evans RJ, Shrom SH. Augmentation ileocystoplasty in neuropathic bladder. Urology. 1985;25(1):26–30.CrossRefPubMed
8.
Linder A, Leach GE, Raz S. Augmentation cystoplasty in the treatment of neurogenic bladder dysfunction. J Urol. 1983;129(3):491–3.PubMed
9.
Krishna A, Gough DC, Fishwick J, et al. Ileocystoplasty in children: assessing safety and success. Eur Urol. 1995;27(1):62–6.PubMed
10.
Krishna A, Gough DC. Evaluation of augmentation cystoplasty in childhood with reference to vesico-ureteric reflux and urinary infection. Br J Urol. 1994;74(4):465–8.CrossRefPubMed
11.
Casale AJ, Metcalfe PD, Kaefer MA, et al. Total continence reconstruction: a comparison to staged reconstruction of neuropathic bowel and bladder. J Urol. 2006;176:1712–5.CrossRefPubMed
12.
Herndon CDA, Rink RC, Shaw MBK, et al. The Indiana experience with artificial urinary sphincter in children and young adults. J Urol. 2003;169:650–4.CrossRefPubMed
13.
Venn SN, Mundy AR. Long-term results of augmentation cystoplasty. Eur Urol. 1998;34 Suppl 1:40–2.CrossRefPubMed
14.
Herschron S, Hewitt R. Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology. 1998;52:672–8.CrossRef
15.
Watanabe T, Rivas DA, Smith R, et al. The effect of urinary tract reconstruction on neurologically impaired women previously treated with an indwelling urethral catheter. J Urol. 1996;156(6):1926–8.CrossRefPubMed
16.
MacNeily AE, Morrell J, Secord S. Lower urinary tract reconstruction for spina bifida—does it improve health related quality of life? J Urol. 2005;174:1637–43.CrossRefPubMed
17.
MacNeily AE, Jafari S, Scott H, et al. Behavioral effects of lower urinary tract dysfunction health related quality of life in patients with spina bifida: a prospective assessment before and after lower urinary tract reconstruction. J Urol. 2009;182:1984–92.CrossRefPubMed
18.
Szymanski KM, Misseri R, Whittam B, et al. QUAlity of life assessment in spina bifida for adults (QUALAS-A): development and international validation of a novel health-related quality of life instrument. Qual Life Res. 2015;24(10):2355–64.CrossRefPubMed
19.
Joseph DB, Borer JG, De Filippo RE, et al. Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida. J Urol. 2014;191:1389–95.CrossRefPubMed
20.
Schaefer M, Kaiser A, Stehr M, et al. Bladder augmentation with small intestinal submucosa leads to unsatisfactory long-term results. J Pediatr Urol. 2013;9:878–83.CrossRefPubMed
21.
Merriman LS, Arlen AM, Kirsch AJ, et al. Does augmentation cystoplasty with continent reconstruction at a young age increase the risk of complications or secondary surgeries? J Pediatr Urol. 2015;11(1):41.e1–5.CrossRef
22.
Metcalfe PD, Casale AJ, Kaefer MA, et al. Spontaneous bladder perforations: a report of 500 augmentations in children and analysis of risk. J Urol. 2006;175:1466–71.CrossRefPubMed
23.
Blyth B, Ewalt DH, Duckett JW, et al. Lithogenic properties of enterocystoplasty. J Urol. 1992;148(2 Pt 2):575–7. discussion 578–9.PubMed
24.
Palmer LS, Franco I, Reda EF, et al. Endoscopic management of bladder calculi following augmentation cystoplasty. Urology. 1994;44(6):902–4.CrossRefPubMed
25.
Mathoera RB, Kok DJ, Nijman RJ. Bladder calculi in augmentation cystoplasty in children. Urology. 2000;56(3):482–7.CrossRefPubMed
26.
DeFoor W, Minevich E, Reddy P, et al. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol. 2004;172(5 Pt 1):1964–6.CrossRefPubMed
27.
Kaefer M, Hendren WH, Bauer SB, et al. Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments. J Urol. 1998;160(6 Pt 1):2187–90.PubMed
28.
Kronner KM, Casale AJ, Cain MP, et al. Bladder calculi in the pediatric augmented bladder. J Urol. 1998;160(3 Pt 2):1096–8.CrossRefPubMed
29.
Palmer LS, Franco I, Kogan SJ, et al. Urolithiasis in children following augmentation cystoplasty. J Urol. 1993;150(2 Pt 2):726–9.PubMed
30.
Khoury AE, Salomon M, Doche R, et al. Stone formation after augmentation cystoplasty: the role of intestinal mucus. J Urol. 1997;158(3 Pt 2):1133–7.PubMed
31.
Clark T, Pope IV JC, Adams MC, et al. Factors that influence outcomes of the Mitrofanoff and Malone antegrade continence enema reconstructive procedures in children. J Urol. 2002;168(4 Pt 1):1537–40. discussion 1540.CrossRefPubMed
32.
Misseri R, Szymanski K, Whittam B, et al. Infectious bladder stones after bladder augmentation are not what they seem. Paper presented at 25th annual congress of European Society of Pediatric Urology, Innsbruck, Austria: 2014.
33.
Kisku S, Sen S, Karl S, et al. Bladder calculi and the augmented bladder: a follow-up study of 160 children and adolescents. J Pediatr Urol. 2015;11(2):66.e1–6.CrossRef
34.
Salah MA, Holman E, Khan AM, et al. Percutaneous cystolithotomy for pediatric endemic bladder stone: experience with 155 cases from 2 developing countries. J Pediatr Surg. 2005;40(10):1628–31.CrossRefPubMed
35.
Rhee AC, Cain MP. Percutaneous cystolithotomy in the pediatric neuropathic bladder with laparoscopic trocar access: a modified approach useful for the augmented and native bladder, and continent urinary reservoir. J Pediatr Urol. 2013;9(3):289–92.CrossRefPubMed
36.••
Szymanski KM, Misseri R, Whittam B, et al. Cutting for stone in augmented bladders: what is the risk of recurrence and is it impacted by treatment modality? J Urol. 2014;191(5):1375–80. Outlines the risk of bladder stones and risk of bladder stone recurrence.CrossRefPubMed
37.
Mingin GC, Nguyen HT, Mathias RS, et al. Growth and metabolic consequences of bladder augmentation in children with myelomeningocele and bladder exstrophy. Pediatrics. 2002;110(6):1193–8.CrossRefPubMed
38.
Hafez AT, McLorie G, Gilday D, et al. Long-term evaluation of metabolic profile and bone mineral density after ileocystoplasty in children. J Urol. 2003;170(4 Pt 2):1639–41.CrossRefPubMed
39.
Koch MO, McDougal WS, Thompson CO. Mechanisms of solute transport following urinary diversion through intestinal segments: an experimental study with rats. J Urol. 1991;146(5):1390–4.PubMed
40.
Dahl DM, McDougal WS. Use of intestinal segments in urinary diversion. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. Philadelphia: Saunders Elsevier; 2012.
41.
Mingin G, Maroni P, Gerharz EW, et al. Linear growth after enterocystoplasty in children and adolescents: a review. World J Urol. 2004;22(3):196–9.CrossRefPubMed
42.
Stein R, Schröder A, Thüroff JW. Bladder augmentation and urinary diversion in patients with neurogenic bladder: non-surgical considerations. J Pediatr Urol. 2012;8(2):145–52.CrossRefPubMed
43.
Richards P, Chamberlain MJ, Wrong OM. Treatment of osteomalacia of renal tubular acidosis by sodium bicarbonate alone. Lancet. 1972;2(7785):994–7.CrossRefPubMed
44.
Siklos P, Davie M, Jung RT, et al. Osteomalacia in ureterosigmoidostomy: healing by correction of the acidosis. Br J Urol. 1980;52(1):61–2.CrossRefPubMed
45.
Perry W, Allen LN, Stamp TC, et al. Vitamin D resistance in osteomalacia after ureterosigmoidostomy. N Engl J Med. 1977;297(20):1110–2.CrossRefPubMed
46.
Flood HD, Malhotra SJ, O'Connell HE, et al. Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn. 1995;14(4):297–309.CrossRefPubMed
47.
Bertschy C, Bawab F, Liard A, et al. Enterocystoplasty complications in children. A study of 30 cases. Eur J Pediatr Surg. 2000;10(1):30–4.CrossRefPubMed
48.
Shekarriz B, Upadhyay J, Demirbilek S, et al. Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology. 2000;55(1):123–8.CrossRefPubMed
49.
DeFoor W, Tackett L, Minevich E, et al. Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology. 2003;62(4):737–41.CrossRefPubMed
50.
Elder JS, Snyder HM, Hulbert WC, et al. Perforation of the augmented bladder in patients undergoing clean intermittent catheterization. J Urol. 1988;140(5 Pt 2):1159–62.PubMed
51.
Rushton HG, Woodard JR, Parrott TS, et al. Delayed bladder rupture after augmentation enterocystoplasty. J Urol. 1988;140(2):344–6.PubMed
52.
Anderson PA, Rickwood AM. Detrusor hyper-reflexia as a factor in spontaneous perforation of augmentation cystoplasty for neuropathic bladder. Br J Urol. 1991;67(2):210–2.CrossRefPubMed
53.
Crane JM, Scherz HS, Billman GF, et al. Ischemic necrosis: a hypothesis to explain the pathogenesis of spontaneously ruptured enterocystoplasty. J Urol. 1991;146(1):141–4.PubMed
54.
Rosen MA, Light JK. Spontaneous bladder rupture following augmentation enterocystoplasty. J Urol. 1991;146(5):1232–4.PubMed
55.
Bauer SB, Hendren WH, Kozakewich H, et al. Perforation of the augmented bladder. J Urol. 1992;148(2 Pt 2):699–703.PubMed
56.
Yerkes EB, Rink RC, Cain MP, et al. Shunt infection and malfunction after augmentation cystoplasty. J Urol. 2001;165:2262–4.CrossRefPubMed
57.
Pope JC, Albers P, Rink RC, et al. Spontaneous rupture of the augmented bladder from silence to chaos. Paper presented at 10th annual congress of European Society of Pediatric Urology, Istanbul, Turkey: 1999.
58.
Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318(26):1720–8.CrossRefPubMed
59.
Healton EB, Savage DG, Brust JC, et al. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70(4):229–45.CrossRef
60.
Rosenbaum DH, Cain MP, Kaefer M, et al. Ileal enterocystoplasty and B12 deficiency in pediatric patients. J Urol. 2008;179:1544–8.CrossRefPubMed
61.
Blackburn SC, Parkar S, Prime M, et al. Ileal bladder augmentation and vitamin B12: levels decrease with time after surgery. J Pediatr Urol. 2012;8(1):47–50.CrossRefPubMed
62.
Vanderbrink BA, Cain MP, King S, et al. Is oral vitamin B(12) therapy effective for vitamin B(12) deficiency in patients with prior ileocystoplasty? J Urol. 2010;184(4):1781–5.CrossRefPubMed
63.
Keenan AC, Whittam BM, Rink R, et al. Vitamin B12 deficiency in patients with prior enterocystoplasty. J Pediatr Urol. 2015.
64.
Golomb J, Klutke CG, Lewin KJ, et al. Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. J Urol. 1989;142(2 Pt 1):377–80.PubMed
65.
Nurse DE, Mundy AR. Assessment of the malignant potential of cystoplasty. Br J Urol. 1989;64(5):489–92.CrossRefPubMed
66.
Filmer RB, Spencer JR. Malignancies in bladder augmentations and intestinal conduits. J Urol. 1990;143(4):671–8.PubMed
67.
Barrington JW, Fulford S, Griffiths D, et al. Tumors in bladder remnant after augmentation enterocystoplasty. J Urol. 1997;157(2):482–5. discussion 485–6.CrossRefPubMed
68.
Lane T, Shah J. Carcinoma following augmentation ileocystoplasty. Urol Int. 2000;64(1):31–2.CrossRefPubMed
69.
Soergel TM, Cain MP, Misseri R, et al. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172(4 Pt 2):1649–51.CrossRefPubMed
70.
Castellan M, Gosalbez R, Perez-Brayfield M, et al. Tumor in bladder reservoir after gastrocystoplasty. J Urol. 2007;178(4 Pt 2):1771–4. discussion 1774.CrossRefPubMed
71.
72.
Vemulakonda VM, Lendvay TS, Shnorhavorian M, et al. Metastatic adenocarcinoma after augmentation gastrocystoplasty. J Urol. 2008;179(3):1094–6. discussion 1097.CrossRefPubMed
73.
Husmann DA, Rathbun SR. Long-term follow up of enteric bladder augmentations: the risk for malignancy. J Pediatr Urol. 2008;4(5):381–6.CrossRefPubMed
74.•
Higuchi TT, Granberg CF, Fox JA, et al. Augmentation cystoplasty and risk of neoplasia: fact, fiction and controversy. J Urol. 2010;184(6):2492–6. Showed that bladder augmentation does not increase the risk of bladder malignancy.CrossRefPubMed
75.
Harzmann R, Weckermann D. Problem of secondary malignancy after urinary diversion and enterocystoplasty. Scand J Urol Nephrol. 1992;142:56.
76.
Metcalfe PD, Rink RC. Bladder augmentation: complications in the pediatric population. Curr Urol Rep. 2007;8(2):152–6.CrossRefPubMed
77.
Gepi-Attee S, Ganabathi K, Abrams PH, et al. Villous adenoma in augmentation colocystoplasty: a case report and discussion of the pathogenesis. J Urol. 1992;147(1):128–30.PubMed
78.
Gerharz EW, Turner WH, Kalble T, et al. Metabolic and functional consequences of urinary reconstruction with bowel. BJU Int. 2003;91(2):143–9.CrossRefPubMed
79.••
Higuchi TT, Fox JA, Husmann DA. Annual endoscopy and urine cytology for the surveillance of bladder tumors after enterocystoplasty for congenital bladder anomalies. J Urol. 2011;186(5):1791–5. Provides recommendations for screening for malignancy following augmentation cystoplasty.CrossRefPubMed
80.
Kokorowski PJ, Routh JC, Borer JG, et al. Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis. J Urol. 2011;186(4):1437–43.CrossRefPubMed
81.
Austin JC, Elliott S, Cooper CS. Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol. 2007;178:798–801.CrossRefPubMed
82.
Szymanski KM, Misseri R, Whittam B, et al. Long-term outcomes of catheterizable continent urinary channels: what do you use, where do you put it and does it matter? J Pediatr Urol. 2015;11(4):210.e1–7.CrossRef
83.
Whittam B, Szymanski KM, Flack C, et al. A comparison of the monti and spiral monti procedures: a long-term analysis. J Pediatr Urol. 2015;11(3):134.e1–6.CrossRef
84.
Szymanski KM, Rink RC, Whittam B, et al. Long-term outomces of the Kropp and Salle urethral lengthening bladder neck reconstruction procedures. Paper presented at 2014 Pediatric Urology Fall Congress, Miami, FL: 2014.
85.
Donnahoo KK, Rink RC, Cain MP, et al. The Young-Dees-Leadbetter bladder neck repair for neurogenic incontinence. J Urol. 1999;161:1946–9.CrossRefPubMed
86.
Morello VA, Chocarro G, Lobato R, et al. Quality of life in female epispadias. Eur J Pediatr Surg. 2015.
87.
Castellan M, Gosalbez R, Labbie A, et al. Bladder neck sling for treatment of neurogenic incontinence in children with augmentation cystoplasty: long-term follow up. J Urol. 2005;173(6):2128–31.CrossRefPubMed
88.
Misseri R, Cain MP, Casale AJ, et al. Small intestinal submucosa bladder neck slings for incontinence associated with neuropathic bladder. J Urol. 2005;174:1680–2.CrossRefPubMed
89.
Snodgrass W, Villanueva C, Gargollo P, et al. New hydronephrosis and/or vesicoureteral reflux after bladder outlet surgery without augmentation in 75 children with neurogenic bladder. J Pediatr Urol. 2014;10(5):906–10.CrossRefPubMed
90.
Grimsby GM, Menon V, Schlomer BJ, Baker LA, Adams R, Gargollo PC, Jacobs MA. Long Term Outcomes of Bladder Neck Reconstruction without Augmentation Cystoplasty in Children. J Urol. doi:10.​1016/​j.​juro.​2015.​06.​103
91.
Dave S, Pippi Salle JL, Lorenzo AJ, et al. Is long-term bladder deterioration inevitable following successful isolated bladder outlet procedures in children with neuropathic bladder dysfunction? J Urol. 2008;179(5):1991–6.CrossRefPubMed
92.
Whittam B, Szymanski KM, Misseri R, et al. Long-term fate of the bladder after isolated bladder neck procedure. J Pediatr Urol. 2014;10(5):886–91.CrossRefPubMed
Metadaten
Titel
Long-Term Sequela of Pediatric Bladder Reconstruction
verfasst von
Joshua Roth
Alison Keenan
Mark Cain
Benjamin Whittam
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 4/2015
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-015-0336-1

Weitere Artikel der Ausgabe 4/2015

Current Bladder Dysfunction Reports 4/2015 Zur Ausgabe

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Evaluation and Management of Failed Bladder Reconstructions

Geriatric Bladder Dysfunction (GM Ghoniem, Section Editor)

Urinary Diversion in the Elderly

Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)

Emerging Concepts in Transitional Care of Congenital Genitourinary Reconstructions

Neurogenic Bladder (CR Powell, Section Editor)

Literature Review: Long-Term Complications of the Neurogenic Bladder

Geriatric Bladder Dysfunction (GM Ghoniem, Section Editor)

Effect of Hormonal Changes on Voiding in the Elderly Woman

Neurogenic Bladder (CR Powell, Section Editor)

The Worldwide Economic Impact of Neurogenic Bladder

Neu im Fachgebiet Urologie

Auf Antibiotika verzichten? Was bei unkomplizierter Zystitis hilft

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise